Nuvalent (NUVL)
(Real Time Quote from BATS)
$77.68 USD
-1.44 (-1.82%)
Updated Jul 30, 2024 02:18 PM ET
4-Sell of 5 4
D Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Nuvalent, Inc. [NUVL]
Reports for Purchase
Showing records 1 - 20 ( 33 total )
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Moving Towards a Nu Paradigm in ROS1 and ALK+ NSCLC
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
NVL-655 Looking to Build a Dynasty In ALK+ NSCLC
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
NVL-655 Looking to Build a Dynasty in ALK+ NSCLC
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NUVL 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- 2023 Small Molecule Precision Oncology Review and Outlook
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
EORTC-NCI-AACR 2023: Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
Company: Nuvalent, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D